WallStreetZenWallStreetZen

NASDAQ: SEEL
Seelos Therapeutics Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their SEEL stock forecasts and price targets.

Forecast return on equity

Is SEEL forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is SEEL forecast to generate an efficient return on assets?
Company
N/A
Industry
31.45%

SEEL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SEEL$0.58N/AN/A
APVO$0.31N/AN/A
SLRX$1.98N/AN/A
DRMA$2.28N/AN/A
VRPX$1.36N/AN/A

Seelos Therapeutics Stock Forecast FAQ

What is SEEL's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: SEEL) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Seelos Therapeutics stock.

What is SEEL's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: SEEL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 31.45%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.